Skip to content

Startups

Retinagenix

Startup thumbnail placeholder image

Sectors
Health & Medicine

Launched
01/01/2006

Description

Retinagenix is a biotechnology company, developing and commercializing synthetic retinoids for treatment of retinal diseases.

Team Members

David Saperstein

Co-founder and Chief Medical Officer, and former professor of ophthalmology at University of Washington

Krzysztof Palczewski

Co-founder and John H. Hord Professor and Chair Department of Pharmacology